LMR 9

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

ANTI-dsDNA: most specific antibody for

SLE

Anti-smooth muscle antibody (ASMA):

CHRONIC ACTIVE HEPATITIS

Polymerase chain reaction:

MOLECULAR

: MOLECULAR

Polymerase chain reaction

Restriction fragment length polymorphism:

MOLECULAR

. Enhanced by acidifying patient serum:

anti-M

Wiener and coworkers gave a name to one such agglutinin, calling its antigen I for “?.”

individuality

? and ? gave a name to one such agglutinin, calling its antigen I for “individuality.”

Wiener and coworkers

Wiener and coworkers gave a name to one such agglutinin, calling its antigen ? for “individuality.”

For patients with history of FEBRILE NONHEMOLYTIC TRANSF REACTION:

LEUKOPOOR RBCs

For patients with history of ?: LEUKOPOOR RBCs

FEBRILE NONHEMOLYTIC TRANSF REACTION

Irradiation of blood components:

CESIUM

, results in a fetal blood specimen that can be used for rapid karyotyping or molecular studies.

CORDOCENTESIS, or PERCUTANEOUS UMBILICAL BLOOD SAMPLING (PUBS)

CARD PREGNANCY: If the test band appears VERY FAINT, it is recommended that a new sample be collected ? hours later and tested again using another Card Pregnancy Test device.

The standard screening method for HIV antibody has been the

ELISA

the standard confirmatory test is the

Western blot.

Aside from Western blot, other confirmatory tests, including (3) have also been developed.

indirect immunofluorescence assay (IFA), radioimmunoprecipitation assay (RIPA), line immunoassays, and rapid confirmatory tests,

: active infection

HBs ag

: active hepatitis B with HIGH DEGREE OF INFECTIVITY

HBe ag

: current or recent acute hepatitis B

IgM anti-HBc

: current or past hepatitis B

Total anti-HBc

: recovery from hepatitis B

Anti-HBe

: immunity to hepatitis B

Anti-HBs

: acute, atypical, or occult hepatitis B; viral load may be used to monitor effectiveness of therapy

HBV DNA

: inflammation

ITIS

SEVEN BASE SI UNITS Length:

METER

SEVEN BASE SI UNITS Length:

Mass: KILOGRAM

SEVEN BASE SI UNITS Time:

SECONDS

SEVEN BASE SI UNITS Quantity of mass:

MOLE

SEVEN BASE SI UNITS Electric current:

AMPERE

SEVEN BASE SI UNITS Thermodynamic temperature:

KELVIN

SEVEN BASE SI UNITS Luminous intensity:

CANDELA

Main cause of TREND is

DETERIORATION OF REAGENTS

Main cause of SHIFT is

IMPROPER CALIBRATION OF THE INSTRUMENT

: near-patient testing, decentralized testing, bedside testing and alternate-site testing

POCT

: usually by nonlaboratorian personnel (nurses, respiratory therapists, etc)

POCT

Absorbance (A) =

abc = 2-log%T

The bacteriological examination of water consists of (1) total plate counts (2) detecting the presence or absence of coliforms and the estimation of ?

MPN (MOST PROBABLE NUMBER)

Water analysis, presumptive test: FORMATION OF

GAS IN THE LACTOSE BROTH

Water analysis, confirmed test: FORMATION OF GAS IN

BGBL BROTH or TYPICAL COLIFORM COLONIES ON EMB/ENDO AGAR

Water analysis, completed test: FORMATION OF ? IN THE LACTOSE BROTH and the DEMONSTRATION OF GRAM NEGATIVE NONSPOREFORMING BACILLI

ACID AND GAS

Water analysis, completed test: FORMATION OF ACID AND GAS IN THE LACTOSE BROTH and the DEMONSTRATION OF ?

GRAM NEGATIVE NONSPOREFORMING BACILLI

: cardinal feature of the group is LATENCY

Herpesviruses

Herpesviruses: cardinal feature of the group is

LATENCY

Reoviruses: derivation of the word:

R(respiratory), E(enteric), O(orphan)

ASCHOFF BODIES:

rheumatic fever

: rheumatic fever

ASCHOFF BODIES

: cluster of columnar cells, bronchial asthma

CREOLA BODIES

: infectious particles of Chlamydia

ELEMENTARY BODIES

ELEMENTARY BODIES: infectious particles of

Chlamydia

: dark brown-black organisms, chromoblastomycosis

SCLEROTIC BODIES

: concentric radiating eosinophilic material (ag-ab reaction), sporotrichosis

ASTEROID BODIES

SCLEROTIC BODIES: dark brown-black organisms, ?

chromoblastomycosis

ASTEROID BODIES: concentric radiating eosinophilic material (ag-ab reaction), ?

sporotrichosis

: rabies

NEGRI BODIES

rabies

: poxvirus

GUARNIERI BODIES

GUARNIERI BODIES:

poxvirus

: cytomegalovirus

OWL’S EYE INCLUSION BODIES

OWL’S EYE INCLUSION BODIES:

cytomegalovirus

: elements with concentric striations of collagen-like materials, benign conditions, ovarian or thyroid carcinoma

PSAMMOMA BODIES

KOPLIK’S SPOTS:

MEASLES

: MEASLES

KOPLIK’S SPOTS

Hand, foot and mouth disease:

COXSACKIEVIRUS

In ? of the pancreas, the increase IN NEUTRAL FATS confer the greasy “BUTTER-STOOL” appearance.

CYSTIC FIBROSIS

In CYSTIC FIBROSIS of the pancreas, the increase IN ? confer the greasy “BUTTER-STOOL” appearance.

NEUTRAL FATS

In CYSTIC FIBROSIS of the pancreas, the increase IN NEUTRAL FATS confer the greasy “?” appearance.

BUTTER-STOOL

PROGRESSIVE CHANGES - increase in size of an organ due to an increase in size of individual cells

Hypertrophy

PROGRESSIVE CHANGES - increase in size of an organ due to increase in number of cells

Hyperplasia

RETROGRESSIVE CHANGES - failure of an organ to reach mature size

Hypoplasia

RETROGRESSIVE CHANGES - organ is represented only by mass of fatty or fibrous nodule

Aplasia

RETROGRESSIVE CHANGES - complete non-appearance of an organ

Agenesia

RETROGRESSIVE CHANGES - failure of an organ to form an opening

Atresia

RETROGRESSIVE CHANGES - ACQUIRED decrease in size of a normally sized organ

Atrophy

DEGENERATIVE CHANGES - change in size, shape and orientation of cell

Dysplasia

DEGENERATIVE CHANGES - change from one adult cell type to another

Metaplasia

DEGENERATIVE CHANGES - change to a more primitive or embryonic cell type

Anaplasia or Dedifferentiation

DEGENERATIVE CHANGES - continuous abnormal proliferation of cells

Neoplasia or Tumor

MALIGNANT TUMOR - malignant tumor of EPITHELIAL TISSUE origin

Carcinoma

MALIGNANT TUMOR Carcinoma - malignant tumor of ? origin

EPITHELIAL TISSUE

MALIGNANT TUMOR - malignant tumor of CONNECTIVE TISSUE origin

Sarcoma

MALIGNANT TUMOR Sarcoma - malignant tumor of ? origin

CONNECTIVE TISSUE

PRIMARY SIGNS OF DEATH (3)

Respiratory, circulatory and nervous failure

SECONDARY SIGNS OF DEATH (7)

ARaL PA?? Di PA (ARLPADPA) Algor mortis - cooling Rigor mortis - stiffening Liver mortis - purplish discoloration Postmortem clotting Dessication Putrefaction Autolysis

- cooling

Algor mortis

- stiffening

Rigor mortis

- purplish discoloration

Liver mortis

CLASS SYSTEM - absence of atypical cytologic picture

Class I

CLASS SYSTEM - atypical cytologic picture but no evidence of malignancy

Class II

CLASS SYSTEM - cytologic picture SUGGESTIVE BUT NOT CONCLUSIVE of malignancy

Class III

CLASS SYSTEM - cytologic picture STRONGLY SUGGESTIVE of malignancy

Class IV

CLASS SYSTEM - cytologic picture CONCLUSIVE of malignancy.

Class V

Visceral larva migrans (VLM):

Toxocara cati, Toxocari canis

Cutaneous larva migrans (CLM):

Ancylostoma braziliense, A. caninum

Infective stage is the sheathed filariform larva:

HOOKWORM

Infective stage is the unsheathed filariform larva:

THREADWORM

Semilunar cutting plates, BIPARTITE bursa:

NECATOR AMERICANUS

. Two pairs of teeth, TRIPARTITE bursa:

ANCYLOSTOMA DUODENALE

Alkaline phosphatase immunoassay (APIA) for ? antibodies

Schistosoma

100

for antibodies

Alkaline phosphatase immunoassay (APIA)

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前